SCHEMBL30391887

SCHEMBL30391887

O=C(O)CN(CC(=O)NCCCCCNC(=O)OCc1ccccc1)CC(=O)NCCCCCC(=O)NCCO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]1O

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MMP13 P45452 1/20 0.45
▸ HTT P42858 1/20 0.42
▸ SIRT2 Q8IXJ6 2/20 0.41
▸ MAOB P27338 1/20 0.39
▸ TGM2 P21980 1/20 0.39
▸ LMNA P02545 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ FOLH1 Q04609 3/20 0.39
▸ LGALS8 O00214 1/20 0.38
▸ SYNJ2 O15056 2/20 0.37
▸ KDM4E B2RXH2 1/20 0.37
▸ ABL1 P00519 1/20 0.37
▸ ALPL P05186 1/20 0.37
▸ POLB P06746 1/20 0.37
▸ ALPI P09923 1/20 0.37
▸ GAA P10253 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ ALPG P10696 1/20 0.37
▸ PABPC1 P11940 1/20 0.37
▸ RECQL P46063 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30391867 0.94 LMNA (0.43) MMP13HTTMAOBTGM2LMNA
SCHEMBL30891325 0.93 HTT (0.46) MMP13HTTSIRT2MAOBTGM2
SCHEMBL30391620 0.93 HTT (0.46) MMP13HTTSIRT2MAOBTGM2
SCHEMBL25417921 0.92 MMP13 (0.43) MMP13MAOBLGALS8SYNJ2KDM4E
SCHEMBL30392241 0.92 MMP13 (0.43) MMP13MAOBLGALS8SYNJ2KDM4E
SCHEMBL30891306 0.90 MMP13 (0.47) MMP13HTTSIRT2MAOBLGALS8
SCHEMBL20510407 0.90 HTT (0.42) MMP13HTTSIRT2TGM2LMNA
SCHEMBL29454860 0.90 MMP13 (0.44) MMP13MAOBLGALS8SYNJ2KDM4E
SCHEMBL25243911 0.90 MMP13 (0.44) MMP13MAOBLGALS8SYNJ2KDM4E
SCHEMBL30891375 0.89 SIRT2 (0.44) MMP13SIRT2FOLH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4615487-A1 GLUCOSE-RESPONSIVE INSULIN CONJUGATES COMPRISING A PENTA-VALENT SUGAR CLUSTER FOR TREATMENT OF DIABETES Merck Sharp & Dohme LLC (US) 2025-09-17 — — EP disclosed
EP-4436610-A1 GLUCOSE-RESPONSIVE INSULIN CONJUGATES COMPRISING A TETRA-VALENT SUGAR CLUSTER FOR TREATMENT OF DIABETES Merck Sharp & Dohme LLC (US) 2024-10-02 — — EP disclosed
WO-2024102633-A1 GLUCOSE-RESPONSIVE INSULIN CONJUGATES COMPRISING A PENTA-VALENT SUGAR CLUSTER FOR TREATMENT OF DIABETES MERCK SHARP & DOHME LLC (US) 2024-05-16 — — WO disclosed
WO-2023091441-A1 GLUCOSE-RESPONSIVE INSULIN CONJUGATES COMPRISING A TETRA-VALENT SUGAR CLUSTER FOR TREATMENT OF DIABETES MERCK SHARP & DOHME LLC (US) 2023-05-25 — — WO disclosed
Send feedback